Table 1.

Baseline characteristics of the 37 patients with chronic hepatitis B virus (HBV) infection

^*P = 0.189 (χ² test); ^†P = 0.061 (Kruskal-Wallis test); ^‡P < 0.001 (Kruskal-Wallis test); ^§P < 0.001 (Kruskal-Wallis test); ^∥P ≤ 0.001 (χ² test); ^¶Mean ± 2SD. ITP, immune tolerance phase; ICP, immune clearance phase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; high, > 10⁸ copies/mL; moderate, 10⁵-10⁸ copies/mL; low, 10²-10⁵ copies/mL; negative, < 10² copies/mL. From 3 to 5 samples of each patient, the highest value out of laboratory data and the value at the time of mutation were selected in the patients without and with precore/core gene mutation, respectively.